Am J Transplant, Volume 17, Suppl 3 Archives - Page 163 of 181 - ATC Abstracts

2017 American Transplant Congress
Outcome After Living Donor Liver Transplantation for Hepatocellular Carcinoma in Elderly Patients > 65 Years: Assessing the Long Term Survival.
A. Thorat, S.-C. Hsu, L.-B. Jeng, H.-R. Yang, P.-C. Li, C.-C. Yeh, T.-H. Chen, K.-S. Poon.
Organ Transplantation, China Medical University Hospital, Taichung, Taiwan
Background:In Asia, the hepatocellular carcinoma (HCC) is most common cancer. Despite of the surveillance most tumors are diagnosed at late stages and thus HCC continues…
2017 American Transplant Congress
Kidney Allograft Offers: Predictors of Turndown and the Relationship of Organ Acceptance Sequence to Kidney Allograft Survival.
J. Cohen,^1,2 J. Shults,² D. Goldberg,^2,3 D. Sawinski,¹ P. Abt,⁴ P. Reese.^1,2
¹Renal Division, University of Pennsylvania, Philadelphia, PA; ²Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA; ³Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA; ⁴Transplant Surgery, University of Pennsylvania, Philadelphia, PA
Background: There is growing interest in understanding patterns of organ acceptance and reducing organ discard. Little is known about how donor factors, holidays, and location…
2017 American Transplant Congress
Charlson Comorbidity Index (CCI) as Prognostic Indicator of Outcomes in Older Patients Undergoing Renal Transplantation.
A. Asderakis, U. Contractor, U. Khalid, P. Donato, L. Szabo.
Cardiff Transplant Unit, University Hospital of Wales, Cardiff, United Kingdom
Introduction: Our group has shown excellent results using old DCD donor kidneys to older recipients. There are continuing efforts to predict those older recipients who…
2017 American Transplant Congress
Validation of CYP4F11 as a Marker of Accommodation in Biopsies from Recipients of an ABO-Incompatible Renal Transplant.
K. Dominy,¹ M. Willicombe,³ T. Al Johani,² J. Galliford,³ A. McLean,³ T. Cook,³ C. Roufosse.³
¹Centre for Complement and Inflammation Research, Imperial College, London, United Kingdom; ²King Saud University, Riyadh, Saudi Arabia; ³Imperial College Healthcare NHS Trust, London, United Kingdom
Recipients of an ABO incompatible transplant have circulating anti-AB antibodies, A and/or B antigens expressed on endothelium and usually C4d deposition on the endothelium, yet…
2017 American Transplant Congress
Clinically Relevant Immunosuppression Promotes MCMV Reactivation and Dissemination Following Transplantation of Latently Infected Kidneys.
Z. Zhang,¹ S. Yan,¹ L. Zhao,¹ S. Kurian,² M. Hummel,¹ D. Salomon,² M. Abecassis.¹
¹Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago; ²Dept. of Molecular & Experimental Medicine, The Scripps Research Institute, La Jolla
Reactivation of latent Cytomegalovirus (CMV) is an important problem facing clinical transplantation. We have previously described a model for murine CMV (MCMV) reactivation following kidney…
2017 American Transplant Congress
Enhanced Liver Regeneration After Partial Hepatectomy in Mice Treated with a Prolyl Hydroxylase Inhibitor.
J. Latona,¹ A. Shah,¹ J. Cheng,² P. Messersmith,² E. Heber-Katz.³
¹Thomas Jefferson University, Philadelphia, PA; ²University of California, Berkeley, Berkeley, CA; ³Lankenau Institute for Medical Research, Wynnewood, PA
Purpose: Resection of more than 70% of liver mass increases incidence of post-operative hepatic failure due to an inability of the liver remnant to adequately…
2017 American Transplant Congress
Clearance of Transaminases During Normothermic Ex Vivo Liver Perfusion.
M. Bral,¹ N. Aboelnazar,² B. Gala-Lopez,² S. Hatami,² D. Freed,¹ A. Shapiro.¹
¹Department of Transplant Surgery, University of Alberta, Edmonton, AB, Canada; ²Department of Experimental Surgery, University of Alberta, Edmonton, AB, Canada
One of the most promising applications of normothermic ex vivo liver perfusion is the possibility of real-time graft viability assessment. Many liver biomarkers are considered…
2017 American Transplant Congress
Solid Organ Cancer After Kidney Transplantation: Risk Factors and Long Term Impact.
A. Buxeda, D. Redondo, M. Pérez-Sáez, A. Bartolomé, M. Mir, A. Pascual, A. Sans, M. Crespo, J. Pascual.
Nephrology Department, Hospital del Mar, Barcelona, Spain
Cancer after kidney transplant (KT) is the only cause of death that is increasing. We analyzed incidence, risk factors and characteristics of postKT solid cancers…
2017 American Transplant Congress
Ciprofloxacin for Urinary Tract Infection Prophylaxis in Post-Renal Transplant Patients with Ureteral Stent Placement.
P. Kakadiya, M. Levy, G. Gupta, A. King, S. LeCorchick.
Hume-Lee Transplant Center, Virginia Commonwealth University Health, Richmond, VA
BackgroundUrinary tract infection (UTI) is the most common infection post renal transplant. Sulfamethoxazole-trimethoprim (SMX-TMP) is often the antibiotic drug of choice due to prophylaxis coverage…
2017 American Transplant Congress
BK Viruria Levels within 3 Months Post Renal Transplantation Can Predict the Development of BK Viraemia.
N. Lioufas,¹ R. Masterson,^1,2 P. Hughes.
¹Department of Nephrology, Royal Melbourne Hospital, Parkville, Victoria, Australia; ²Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia
Aim: To determine the utility of screening for BK viruria (BKVR) to predict the development of BK viraemia within the first year of renal transplantation.Background:…